Biodesix
BDSX
43 hedge funds and large institutions have $23.2M invested in Biodesix in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
13% more funds holding
Funds holding: 38 → 43 (+5)
0.11% less ownership
Funds ownership: 0.94% → 0.84% (-0.11%)
32% less capital invested
Capital invested by funds: $34.1M → $23.2M (-$10.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
+$2.14M |
| 2 |
CS
Cannell & Spears
New York
|
+$352K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$299K |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$133K |
| 5 |
Jane Street
New York
|
+$84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$2.29M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$2.1M |
| 3 |
Renaissance Technologies
New York
|
-$60.9K |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$52.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$48.2K |
BDSX Hedge Fund Activity: Q1 2024 in Review
43 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2024, worth a combined $23.2M — down 32% from $34.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new BDSX positions and 5 closed out — a net gain of 6 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was Telemark Asset Management, adding an estimated $2.14M. The largest seller was AIGH Capital Management, cutting an estimated $2.29M.
- 43 institutional investors held Biodesix (BDSX) as of Q1 2024, up from 38 in Q4 2023.
- Funds reported $23.2M of Biodesix stock for Q1 2024, down 32% quarter-over-quarter.
- 11 funds opened new Biodesix positions in Q1 2024 and 5 closed out, a net change of +6 holders.
- The largest Biodesix buyer in Q1 2024 was Telemark Asset Management, an estimated $2.14M added.
- The largest Biodesix seller in Q1 2024 was AIGH Capital Management, an estimated $2.29M sold.
Based on aggregated 13F filings for Q1 2024.